Profit Or Loss [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
66,997,000 EUR
22,668,000 EUR
Cost of sales
19 623 EUR
15 724 EUR
Gross profit
47 374 EUR
6 945 EUR
Other income
7 196 EUR
4 809 EUR
Profit (loss) from operating activities
26 245 EUR
87 875 EUR
Finance income
9 852 EUR
2 838 EUR
Finance costs
23 422 EUR
13 116 EUR
Profit (loss) before tax
11 480 EUR
123 769 EUR
Tax expense (income)
48 139 EUR
6 895 EUR
Profit (loss)
59 620 EUR
59 620 EUR
116 875 EUR
116 875 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
59 620 EUR
116 875 EUR
Profit (loss), attributable to non-controlling interests
- EUR
- EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
122.00
269.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
122.00
269.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.